| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |